Live from the NIH registry
Studies recruiting near Green Bay right now
Top 25 of 145 recruiting studies, sorted by proximity — each links to its official registry page
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8
Phase 2
Interventional 146 participants sought
Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton — Appleton, Wisconsin (27.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
GyroStim for Post Concussion Syndrome
Post Concussion Syndrome
N/A
Interventional 128 participants sought
Neuroscience Group — Appleton, Wisconsin (27.3 mi)
· Sponsor: Neuroscience Group
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
Aurora BayCare Medical Center — Green Bay, Wisconsin (1.5 mi)
· Sponsor: SWOG Cancer Research Network
Nectero EAST System Clinical Study
Abdominal Aortic Aneurysm
Phase 2, Phase 3
Interventional 400 participants sought
Bellin Memorial Hospital — Green Bay, Wisconsin (1.5 mi)
· Sponsor: Nectero Medical, Inc.
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
HSHS St. Vincent Hospital Regional Cancer Center — Green Bay, Wisconsin (1.5 mi)
· Sponsor: Bristol-Myers Squibb
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Lung Non-Small Cell Carcinoma
Phase 3
Interventional 336 participants sought
Bellin Memorial Hospital — Green Bay, Wisconsin (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 335 participants sought
Saint Vincent Hospital Cancer Center Green Bay — Green Bay, Wisconsin (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Bellin Memorial Hospital — Green Bay, Wisconsin (1.5 mi)
· Sponsor: NRG Oncology
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Bionic Prosthetics & Orthotics — Green Bay, Wisconsin (1.5 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
Phase 3
Interventional 11,300 participants sought
Research Site — Green Bay, Wisconsin (1.5 mi)
· Sponsor: AstraZeneca
Validating a Clinical Prediction Rule to Guide Manual Therapy and Exercise for Neck Pain Relief
Neck Pain Musculoskeletal, Neck Pain Treatment
N/A
Interventional 160 participants sought
Emplify by Bellin Health Ashwaubenon — Green Bay, Wisconsin (1.5 mi)
· Sponsor: Baylor University
The AHA Oneida Study
Oneida Nation Members
N/A
Interventional 95 participants sought
Oneida Nation Reservation — Oneida, Wisconsin (9.6 mi)
· Sponsor: University of Wisconsin, Madison
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Aurora BayCare Medical Center — Green Bay, Wisconsin (1.5 mi)
· Sponsor: American Society of Clinical Oncology
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
Bellin Memorial Hospital — Green Bay, Wisconsin (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Renal Pelvis and Ureter Urothelial Carcinoma
Phase 2, Phase 3
Interventional 131 participants sought
Aurora BayCare Medical Center — Green Bay, Wisconsin (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Saint Vincent Hospital Cancer Center Green Bay — Green Bay, Wisconsin (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Saint Vincent Hospital Cancer Center Green Bay — Green Bay, Wisconsin (1.5 mi)
· Sponsor: Children's Oncology Group
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
Saint Vincent Hospital Cancer Center Green Bay — Green Bay, Wisconsin (1.5 mi)
· Sponsor: NRG Oncology
The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
Cancer
N/A
Interventional 500 participants sought
Aurora BayCare Medical Center — Green Bay, Wisconsin (1.5 mi)
· Sponsor: Eastern Cooperative Oncology Group
Vitamin D for Prostate Endocrine Therapy
Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8
Phase 3
Interventional 240 participants sought
Saint Vincent Hospital Cancer Center Green Bay — Green Bay, Wisconsin (1.5 mi)
· Sponsor: University of Rochester
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma
Phase 2, Phase 3
Interventional 992 participants sought
Saint Vincent Hospital Cancer Center Green Bay — Green Bay, Wisconsin (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma
Phase 2
Interventional 46 participants sought
Aurora BayCare Medical Center — Green Bay, Wisconsin (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Saint Vincent Hospital Cancer Center Green Bay — Green Bay, Wisconsin (1.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Standardized Application of Feeding Evaluations Using SMART Tool
Infant and Young Child Feeding
N/A
Interventional 3,500 participants sought
Aurora BayCare Medical Center — Green Bay, Wisconsin (1.5 mi)
· Sponsor: Wake Forest University Health Sciences
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis
Phase 2
Interventional 48 participants sought
Saint Vincent Hospital Cancer Center Green Bay — Green Bay, Wisconsin (1.5 mi)
· Sponsor: National Cancer Institute (NCI)